CoChat
Sign Up
Cited by 500SARS-CoV-2 and COVID-19 ResearchCellular transport and secretionSARS-CoV-2 detection and testing

The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.

SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis

Open access
Bayati, Armin, Kumar, Rahul, Francis, Vincent, McPherson, Peter S.·2021·Journal of Biological Chemistry
DOI 10.1016/j.jbc.2021.100306PMC PMC7816624

Published version of a preprint

Open this paper in CoChat — free accountOpen PDF

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19, so understanding its biology and infection mechanisms is critical to facing this major medical challenge. SARS-CoV-2 is known to use its spike glycoprotein to interact with the cell surface as a first step in the infection process. As for other coronaviruses, it is likely that SARS-CoV-2 next undergoes endocytosis, but whether or not this is required for infectivity and the precise endocytic mechanism used are unknown. Using purified spike glycoprotein and lentivirus pseudotyped with spike glycoprotein, a common model of SARS-CoV-2 infectivity, we now demonstrate that after engagement with the plasma membrane, SARS-CoV-2 undergoes rapid, clathrin-mediated endocytosis. This suggests that transfer of viral RNA to the cell cytosol occurs from the lumen of the endosomal system. Importantly, we further demonstrate that knockdown of clathrin heavy chain, which blocks clathrin-mediated endocytosis, reduces viral infectivity. These discoveries reveal that SARS-CoV-2 uses clathrin-mediated endocytosis to gain access into cells and suggests that this process is a key aspect of virus infectivity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jbc.2021.100306

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 SARS-CoV-2 spike protein binds to the surface of HEK-293T cells expressing ACE2. A, HEK-293T cells, WT (top row of images), or stably expressing ACE2 (bottom row of images) were incubated with purified, His6-tagged spike protein and with Alexa 647–labeled transferrin (Tf) for 30 min at 4 °C. After PBS wash, the cells were fixed and stained with DAPI to reveal nuclei, with an antibody recognizing the expressed ACE2, and with an antibody recognizing the His6 epitope tag of the spike protein. Scale bars = 40 μm for the low-magnification images and 10 μm for the higher magnification inset of the merged images. B, quantification of experiments as in (A). The bar graph represents fluorescence on the plasma membrane for spike protein and Tf, from three independent experiments, mean ± SEM; unpaired t test; ∗∗∗∗p < 0.0001, n.s, not significant. C, experiments performed as in (A) except that the HEK-293T cells were briefly acid-washed before fixation. Scale bars = 40 μm for the low magnification images and 10 μm for the higher magnification inset of the composite. D, quantification of experiments as in (C). The bar graph represents fluorescence on the plasma membrane for spike protein and Tf, from three independent experiments, mean ± SEM; unpaired t test; ∗∗∗∗p < 0.0001, ∗∗p < 0.01, n.s, not significant. ACE2, angiotensin-converting enzyme 2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Figure 1 SARS-CoV-2 spike protein binds to the surface of HEK-293T cells expressing ACE2. A, HEK-293T cells, WT (top row of images), or stably expressing ACE2 (bottom row of images) were incubated with purified, His6-tagged spike protein and with Alexa 647–labeled transferrin (Tf) for 30 min at 4 °C. After PBS wash, the cells were fixed and stained with DAPI to reveal nuclei, with an antibody recognizing the expressed ACE2, and with an antibody recognizing the His6 epitope tag of the spike protein. Scale bars = 40 μm for the low-magnification images and 10 μm for the higher magnification inset of the merged images. B, quantification of experiments as in (A). The bar graph represents fluorescence on the plasma membrane for spike protein and Tf, from three independent experiments, mean ± SEM; unpaired t test; ∗∗∗∗p < 0.0001, n.s, not significant. C, experiments performed as in (A) except that the HEK-293T cells were briefly acid-washed before fixation. Scale bars = 40 μm for the low magnification images and 10 μm for the higher magnification inset of the composite. D, quantification of experiments as in (C). The bar graph represents fluorescence on the plasma membrane for spike protein and Tf, from three independent experiments, mean ± SEM; unpaired t test; ∗∗∗∗p < 0.0001, ∗∗p < 0.01, n.s, not significant. ACE2, angiotensin-converting enzyme 2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.CC BY · PubMed Central
Figure 2 SARS-CoV-2 spike protein enters cells in an ACE2-dependent manner. A, HEK-293T cells, WT (top row of images), or stably expressing ACE2 (bottom row of images) were incubated with purified, His6-tagged spike protein and with Alexa 647–labeled transferrin (Tf) for 30 min at 4 °C. The cells were then transferred to 37 °C for 30 min. The cells were returned to ice and after acid wash, were fixed and stained with DAPI to reveal nuclei, with an antibody recognizing the expressed ACE2, and with an antibody recognizing the His6 epitope tag of the spike protein. Scale bars = 40 μm for the low-magnification images and 10 μm for the higher magnification inset of the composite. B, quantification of experiment as in (A). The bar graph represents fluorescence on the plasma membrane for spike protein and Tf, from three independent experiments, mean ± SEM; unpaired t test; ∗∗∗p < 0.001, n.s, not significant. ACE2, angiotensin-converting enzyme 2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Figure 2 SARS-CoV-2 spike protein enters cells in an ACE2-dependent manner. A, HEK-293T cells, WT (top row of images), or stably expressing ACE2 (bottom row of images) were incubated with purified, His6-tagged spike protein and with Alexa 647–labeled transferrin (Tf) for 30 min at 4 °C. The cells were then transferred to 37 °C for 30 min. The cells were returned to ice and after acid wash, were fixed and stained with DAPI to reveal nuclei, with an antibody recognizing the expressed ACE2, and with an antibody recognizing the His6 epitope tag of the spike protein. Scale bars = 40 μm for the low-magnification images and 10 μm for the higher magnification inset of the composite. B, quantification of experiment as in (A). The bar graph represents fluorescence on the plasma membrane for spike protein and Tf, from three independent experiments, mean ± SEM; unpaired t test; ∗∗∗p < 0.001, n.s, not significant. ACE2, angiotensin-converting enzyme 2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.CC BY · PubMed Central
Figure 3 Time course of SARS-CoV-2 spike protein entry into cells. A, HEK-293T cells stably expressing ACE2 were incubated with purified, His6-tagged spike protein for 30 min at 4 °C. The cells were then transferred to 37 °C for the indicated time periods before being returned to ice. After acid wash, cells were fixed and stained with DAPI to reveal nuclei and with antibody selectively recognizing the His6 epitope tag of the spike protein. Scale bars = 40 μm for the low-magnification images and 10 μm for the higher magnification insets on the right. B, quantification of experiments as in (A), from three independent experiments, mean ± SEM; one-way ANOVA; ∗∗∗∗p < 0.0001. ACE2, angiotensin-converting enzyme 2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Figure 3 Time course of SARS-CoV-2 spike protein entry into cells. A, HEK-293T cells stably expressing ACE2 were incubated with purified, His6-tagged spike protein for 30 min at 4 °C. The cells were then transferred to 37 °C for the indicated time periods before being returned to ice. After acid wash, cells were fixed and stained with DAPI to reveal nuclei and with antibody selectively recognizing the His6 epitope tag of the spike protein. Scale bars = 40 μm for the low-magnification images and 10 μm for the higher magnification insets on the right. B, quantification of experiments as in (A), from three independent experiments, mean ± SEM; one-way ANOVA; ∗∗∗∗p < 0.0001. ACE2, angiotensin-converting enzyme 2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.CC BY · PubMed Central
Figure 4 SARS-CoV-2 spike protein endocytosis is blocked by chemical inhibitors of clathrin-mediated endocytosis. A, HEK-293 cells stably expressing ACE2 were incubated with purified, His6-tagged spike protein for 30 min at 4 °C. The cells were then transferred to 37 °C for 30 min before being returned to ice. After acid wash, cells were fixed and stained with DAPI to reveal nuclei and with antibody selectively recognizing the His6 epitope tag of the spike protein. Inhibitors of clathrin-mediated endocytosis or their controls, as indicated, were added to the cells 30 min before the addition of spike protein. Scale bars = 40 μm for the low-magnification images and 10 μm for the higher magnification insets on the right. B, quantification of experiments performed as in (A). n = 15 for Dynasore and n = 14 for Pitstop 2 from three independent experiments, mean ± SEM; unpaired t test; ∗∗∗∗p < 0.0001. ACE2, angiotensin-converting enzyme 2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Figure 4 SARS-CoV-2 spike protein endocytosis is blocked by chemical inhibitors of clathrin-mediated endocytosis. A, HEK-293 cells stably expressing ACE2 were incubated with purified, His6-tagged spike protein for 30 min at 4 °C. The cells were then transferred to 37 °C for 30 min before being returned to ice. After acid wash, cells were fixed and stained with DAPI to reveal nuclei and with antibody selectively recognizing the His6 epitope tag of the spike protein. Inhibitors of clathrin-mediated endocytosis or their controls, as indicated, were added to the cells 30 min before the addition of spike protein. Scale bars = 40 μm for the low-magnification images and 10 μm for the higher magnification insets on the right. B, quantification of experiments performed as in (A). n = 15 for Dynasore and n = 14 for Pitstop 2 from three independent experiments, mean ± SEM; unpaired t test; ∗∗∗∗p < 0.0001. ACE2, angiotensin-converting enzyme 2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.CC BY · PubMed Central
Figure 5 SARS-CoV-2 spike protein endocytosis is reduced by CHC knockdown. A, HEK-293T cells stably expressing ACE2 were transfected with control siRNA or with an siRNA established to selectively knockdown the expression of CHC. Cell lysates were prepared and immunoblotted with the indicated antibodies. B, HEK-293T cells stably expressing ACE2, transfected with a control siRNA or an siRNA driving CHC knockdown, were incubated with purified, His6-tagged spike protein for 30 min at 4 °C. The cells were then transferred to 37 °C for 30 min before being returned to ice. After acid wash, cells were fixed and stained with DAPI to reveal nuclei and with antibody recognizing the His6 epitope tag of the spike protein. Scale bars = 40 μm for the low-magnification images and 10 μm for the higher magnification insets on the right. C, quantification of experiments performed as in (B). n = 7 from three independent experiments, mean ± SEM; unpaired t test; ∗∗∗p < 0.001. ACE2, angiotensin-converting enzyme 2; CHC, clathrin heavy chain; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Figure 5 SARS-CoV-2 spike protein endocytosis is reduced by CHC knockdown. A, HEK-293T cells stably expressing ACE2 were transfected with control siRNA or with an siRNA established to selectively knockdown the expression of CHC. Cell lysates were prepared and immunoblotted with the indicated antibodies. B, HEK-293T cells stably expressing ACE2, transfected with a control siRNA or an siRNA driving CHC knockdown, were incubated with purified, His6-tagged spike protein for 30 min at 4 °C. The cells were then transferred to 37 °C for 30 min before being returned to ice. After acid wash, cells were fixed and stained with DAPI to reveal nuclei and with antibody recognizing the His6 epitope tag of the spike protein. Scale bars = 40 μm for the low-magnification images and 10 μm for the higher magnification insets on the right. C, quantification of experiments performed as in (B). n = 7 from three independent experiments, mean ± SEM; unpaired t test; ∗∗∗p < 0.001. ACE2, angiotensin-converting enzyme 2; CHC, clathrin heavy chain; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.CC BY · PubMed Central
Figure 6 SARS-CoV-2 spike protein is rapidly endocytosed in VERO cells. A, lysates were made from HEK-293T cells, WT or expressing ACE2, VERO cells, and A549 cells and were immunoblotted with an antibody recognizing ACE2. B, VERO cells were incubated with purified, His6-tagged spike protein for 30 min at 4 °C. The cells were then transferred to 37 °C for the indicated time periods before being returned to ice. After acid wash, cells were fixed and stained with DAPI to reveal nuclei and with antibody selectively recognizing spike protein. Scale bars = 40 μm for the low-magnification images and 10 μm for the higher magnification insets on the right. C, quantification of experiments performed as in (B) from three independent experiments, mean ± SEM; one-way ANOVA; ∗∗∗∗p < 0.0001, ∗∗p < 0.01. ACE2, angiotensin-converting enzyme 2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Figure 6 SARS-CoV-2 spike protein is rapidly endocytosed in VERO cells. A, lysates were made from HEK-293T cells, WT or expressing ACE2, VERO cells, and A549 cells and were immunoblotted with an antibody recognizing ACE2. B, VERO cells were incubated with purified, His6-tagged spike protein for 30 min at 4 °C. The cells were then transferred to 37 °C for the indicated time periods before being returned to ice. After acid wash, cells were fixed and stained with DAPI to reveal nuclei and with antibody selectively recognizing spike protein. Scale bars = 40 μm for the low-magnification images and 10 μm for the higher magnification insets on the right. C, quantification of experiments performed as in (B) from three independent experiments, mean ± SEM; one-way ANOVA; ∗∗∗∗p < 0.0001, ∗∗p < 0.01. ACE2, angiotensin-converting enzyme 2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.CC BY · PubMed Central
Figure 7 SARS-CoV-2 spike protein endocytosis is reduced by CHC knockdown in VERO cells. A, lysates were made from VERO cells transfected with control siRNA or with an siRNA established to selectively knockdown the expression of CHC. Cell lysates were prepared and immunoblotted with the indicated antibodies. B, VERO cells, treated as in (A), were incubated with purified spike protein for 30 min at 4 °C. The cells were then transferred to 37 °C for the indicated time periods before being returned to ice. After acid wash, cells were fixed and stained with DAPI to reveal nuclei and with antibody selectively recognizing spike protein. Scale bars = 40 μm for the low-magnification images and 10 μm for the higher magnification insets on the right. C, the graph showing quantification of experiments performed as in (B). n = 15 from 3 independent experiments, mean ± SEM; unpaired t test; ∗∗∗∗p < 0.0001, n.s, not significant. ACE2, angiotensin-converting enzyme 2; CHC, clathrin heavy chain; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Figure 7 SARS-CoV-2 spike protein endocytosis is reduced by CHC knockdown in VERO cells. A, lysates were made from VERO cells transfected with control siRNA or with an siRNA established to selectively knockdown the expression of CHC. Cell lysates were prepared and immunoblotted with the indicated antibodies. B, VERO cells, treated as in (A), were incubated with purified spike protein for 30 min at 4 °C. The cells were then transferred to 37 °C for the indicated time periods before being returned to ice. After acid wash, cells were fixed and stained with DAPI to reveal nuclei and with antibody selectively recognizing spike protein. Scale bars = 40 μm for the low-magnification images and 10 μm for the higher magnification insets on the right. C, the graph showing quantification of experiments performed as in (B). n = 15 from 3 independent experiments, mean ± SEM; unpaired t test; ∗∗∗∗p < 0.0001, n.s, not significant. ACE2, angiotensin-converting enzyme 2; CHC, clathrin heavy chain; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.CC BY · PubMed Central
Figure 8 SARS-CoV-2 spike protein follows a trafficking itinerary distinct from transferrin. HEK-293T cells stably expressing ACE2 were incubated with purified, His6-tagged spike protein and Trf-Alexa647 for 30 min at 4 °C. The cells were then transferred to 37 °C for the indicated time periods before being returned to ice. After PBS wash, cells were fixed and stained with DAPI to reveal nuclei and with antibody selectively recognizing the His6 epitope tag of the spike protein. Scale bars = 40 μm for the low-magnification images and 10 μm for the higher magnification insets on the right. ACE2, angiotensin-converting enzyme 2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Figure 8 SARS-CoV-2 spike protein follows a trafficking itinerary distinct from transferrin. HEK-293T cells stably expressing ACE2 were incubated with purified, His6-tagged spike protein and Trf-Alexa647 for 30 min at 4 °C. The cells were then transferred to 37 °C for the indicated time periods before being returned to ice. After PBS wash, cells were fixed and stained with DAPI to reveal nuclei and with antibody selectively recognizing the His6 epitope tag of the spike protein. Scale bars = 40 μm for the low-magnification images and 10 μm for the higher magnification insets on the right. ACE2, angiotensin-converting enzyme 2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.CC BY · PubMed Central
Figure 9 Lentivirus pseudotyped with SARS-CoV-2 spike glycoprotein requires CHC for infectivity. A, HEK-293T cells stably expressing ACE2 or HEK-293T cells were incubated with lentivirus pseudotyped with the SARS-CoV-2 spike glycoprotein for 12 h. Cells were then fixed and stained with DAPI to reveal nuclei. Cells were also imaged for GFP, driven from the pseudovirus. Scale bars = 40 μm. B, HEK-293T cells stably expressing ACE2 were transfected with control siRNA or with an siRNA established to selectively knockdown the expression of CHC. The cells were incubated with lentivirus pseudotyped with the SARS-CoV-2 spike glycoprotein for 12 h. Cells were then fixed and stained with DAPI to reveal nuclei. Cells were also imaged for GFP, driven from the pseudovirus. Scale bars = 40 μm. C, the graph showing quantification of SARS-CoV-2 pseudovirus infection from experiments as in (B). n = 3 from three independent experiments, mean ± SEM; unpaired t test, ∗p < 0.05. ACE2, angiotensin-converting enzyme 2; CHC, clathrin heavy chain; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Figure 9 Lentivirus pseudotyped with SARS-CoV-2 spike glycoprotein requires CHC for infectivity. A, HEK-293T cells stably expressing ACE2 or HEK-293T cells were incubated with lentivirus pseudotyped with the SARS-CoV-2 spike glycoprotein for 12 h. Cells were then fixed and stained with DAPI to reveal nuclei. Cells were also imaged for GFP, driven from the pseudovirus. Scale bars = 40 μm. B, HEK-293T cells stably expressing ACE2 were transfected with control siRNA or with an siRNA established to selectively knockdown the expression of CHC. The cells were incubated with lentivirus pseudotyped with the SARS-CoV-2 spike glycoprotein for 12 h. Cells were then fixed and stained with DAPI to reveal nuclei. Cells were also imaged for GFP, driven from the pseudovirus. Scale bars = 40 μm. C, the graph showing quantification of SARS-CoV-2 pseudovirus infection from experiments as in (B). n = 3 from three independent experiments, mean ± SEM; unpaired t test, ∗p < 0.05. ACE2, angiotensin-converting enzyme 2; CHC, clathrin heavy chain; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

Sorted by citations

See all 500

Related

Metadata

Authors
Bayati, A., Kumar, R., Francis, V., & McPherson, P. S.
Affiliations
Montreal Neurological Institute and Hospital (CA)
Corresponding author
McPherson, Peter S.
ORCID
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2021-01
Volume
296
Pages
100306
ISSN
0021-9258 (ISSN-L)
DOI
10.1016/j.jbc.2021.100306
PMC
PMC7816624
OpenAlex
W3121790907
Cited by
499
References
55
Citations by year
2026: 28 · 2025: 53 · 2024: 87 · 2023: 106 · 2022: 150 · 2021: 70
FWCI
32.78
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Natural Sciences and Engineering Research Council of Canada
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
Keywords
SARS-CoV-2, clathrin-mediated endocytosis, viral entry, spike protein, clathrin heavy chain, endosomal escape, COVID-19 pandemic, infection mechanism
MeSH terms
A549 Cells, Angiotensin-Converting Enzyme 2, SARS-CoV-2, Animals, Chlorocebus aethiops, Endocytosis, Gene Expression Regulation, Genetic Vectors, Humans, Hydrazones, Protein Binding, Endosomes, Sulfonamides, Vero Cells, Signal Transduction, Lentivirus, Clathrin Heavy Chains, RNA, Small Interfering, Virus Internalization, Thiazolidines, Host-Pathogen Interactions, HEK293 Cells, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review